Cambridge, MA, June 13, 2002 — Feinstein Kean Healthcare (FKH), an Ogilvy PR Worldwide Company and leading healthcare and biotechnology communications firm, has been awarded a national Silver SABRE award for its public relations efforts on behalf of Oxford GlycoSciences (OGS). Based in the United Kingdom, OGS is a biopharmaceutical company applying integrated proteomics and genomics for the discovery, development and commercialization of therapeutic products. FKH’s entry won the Silver SABRE, the highest award for industry-specific work, in the biotechnology category. The award was recently presented to FKH at an awards ceremony held in New York City.
The award recognized FKH’s work on behalf of OGS to increase its U.S. visibility by organizing a corporate showcase event, “Proteomics at Warp Speed,” that allowed the biopharmaceutical company to highlight its industry-leading technology advances to key audiences in the business, science and trade media, as well as current and potential pharmaceutical and biotechnology partners and members of the investment community.
“Through this strategic event, OGS was able to increase its visibility substantially within the U.S. and position the Company as a leading proteomics and drug development company,” said FKH managing director Patricia Jones. “We are extremely pleased that the Company’s goal of reaching its desired audiences with its key messages was achieved, and we are honored by the recognition we have received from our peers within the public relations industry.”
The SABRE (Superior Excellence in Branding and Reputation) Awards recognize public relations efforts that demonstrate the highest standards of strategic thinking, innovation, integrity, and effectiveness. The awards are sponsored by the Holmes Group, an analyst firm for the public relations industry, and are judged by industry leaders on the agency and corporate sides of the business.
The OGS showcase meeting team included FKH executive vice president Michelle Linn, vice president Michael Lawson, account supervisor Matt Audette and assistant account executive Hemal Parikh.
About Feinstein Kean Healthcare
Founded in 1987, FKH is a communications and business consulting practice serving a wide variety of healthcare companies, including biopharmaceutical, technology, pharmaceutical, medical product and medical service companies. For more information, visit the Web site at www.fkhealth.com.
About Ogilvy Public Relations Worldwide
Ogilvy Public Relations Worldwide was named “Agency of the Year” in 2000 and 2001 by The Holmes Report and PR Week respectively. Headquartered in New York, Ogilvy PR partners with clients throughout the world from its offices in 60 markets across the United States, Europe, Asia, Australia, and Africa and through global affiliate relationships as part of WPP Group, the world’s largest marketing communications company. Ogilvy PR has specialty practices in Corporate, Entertainment, Health & Medical, Marketing, Public Affairs, and Technology. Its Technology Practice operates under the Alexander Ogilvy brand; the Entertainment Practice operates under the B|W|R brand. Feinstein Kean Healthcare is the firm’s wholly owned healthcare and biotechnology subsidiary. For more information, visit the Web site at www.ogilvypr.com.